CUDC-907 Program Remains Focus for Curis (CRIS) in 2016; Roth Affirms at 'Buy'

Go back to CUDC-907 Program Remains Focus for Curis (CRIS) in 2016; Roth Affirms at 'Buy'

Curis (CRIS) Tops Q4 EPS by 2c

February 29, 2016 7:11 AM EST

Curis (NASDAQ: CRIS) reported Q4 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $2.98 million.

For earnings history and earnings-related data on Curis (CRIS) click here.

... More